Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: A marker of human papillomavirus-related disorders not affected by antiretroviral therapy

Archives of Dermatology

Volumn 147, Issue 5, 2011, Pages 590-596

  Jacobelli, Simon ^a   Laude, Helene ^a   Carlotti, Agnes ^a   Rozenberg, Flore ^a   Deleuze, Jean ^a   Morini, Jean Pierre ^a   Franck, Nathalie ^a   Gorin, Isabelle ^a   Avril, Marie Francoise ^a   Dupin, Nicolas ^a  

^a University Paris Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; FLUOROURACIL; IMIQUIMOD; RETINOIC ACID; UREA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CRYOTHERAPY; EPIDERMODYSPLASIA VERRUCIFORMIS; FAMILY HISTORY; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 3; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 8; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LICHENOID; LYMPHOPROLIFERATIVE DISEASE; MALE; NUCLEOTIDE SEQUENCE; PITYRIASIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CANCER; VIRUS LOAD; WART VIRUS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SKIN; YOUNG ADULT;

EID: 79956095902     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.399     Document Type: Article

References (50)

1. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol. 2006;18(6):362-374. (Pubitemid 44511885)
2. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet. 2002;32(4):579-581. (Pubitemid 35435168)
3. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med. 2008;205(1):35-42. (Pubitemid 351185713)
4. Lutzner MA. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer: a model for viral oncogenesis. Bull Cancer. 1978;65(2):169-182.
5. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92(18):1500-1510.
6. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337(19):1343-1349. (Pubitemid 27467768)
7. Arends MJ, Benton EC, McLaren KM, Stark LA, Hunter JA, Bird CC. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer. 1997;75(5):722-728. (Pubitemid 27091088)
8. Paternoster DM, Cester M, Resente C, et al. Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients. Transplant Proc. 2008;4(6):1877-1880.
9. Ozsaran AA, Ateş T, Dikmen Y, et al. Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy. Eur J Gynaecol Oncol. 1999;20(2):127-130. (Pubitemid 29151456)
10. Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol. 1999;80(pt 9):2437-2443. (Pubitemid 29408373)
11. Prose NS, von Knebel-Doeberitz C, Miller S, Milburn PB, Heilman E. Widespread flat warts associated with human papillomavirus type 5: a cutaneous manifestation of human immunodeficiency virus infection. J Am Acad Dermatol. 1990;23(5, pt 2):978-981. (Pubitemid 20364348)
12. Berger TG, Sawchuk WS, Leonardi C, Langenberg A, Tappero J, Leboit PE. Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease. Br J Dermatol. 1991;124(1):79-83.
13. Barzegar C, Paul C, Saiag P, et al. Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection. Br J Dermatol. 1998;139(1):122-127. (Pubitemid 28338078)
14. Haas N, Fuchs PG, Hermes B, Henz BM. Remission of epidermodysplasia verru-ciformis-like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient. Br J Dermatol. 2001;145(4):669-670. (Pubitemid 36138936)
15. Trauner MA, Ruben BS, Hatcher SL, Lawry MA. Groin eruption in an HIV-positive man: epidermodysplasia verruciformis (EDV). Arch Dermatol. 2002;138(4):527-532.
16. Carré D, Dompmartin A, Verdon R, et al. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol. 2003;42(4):296-300. (Pubitemid 36553228)
17. Hu W, Nuovo G, Willen M, Somach S. Epidermodysplasia verruciformis in two half brothers with HIV infection. J Cutan Med Surg. 2004;8(5):357-360. (Pubitemid 41542425)
18. Davison SC, Francis N, McLean K, Bunker CB. Epidermodysplasia verruciformis-like eruption associated with HIV infection. Clin Exp Dermatol. 2004;29(3):311-312. (Pubitemid 38658479)
19. Mermet I, Guerrini JS, Cairey-Remonnay S, et al. Cervical intraepithelial neoplasia associated with epidermodysplasia verruciformis HPV in an HIV-infected patient: a manifestation of immune restoration syndrome. Eur J Dermatol. 2007;17(2):149-152. (Pubitemid 46456766)
20. Bonamigo R, Maldonado G, Londero RM, Cartell A. Epidermodysplasia verruciformis- like disorder in a teenager with HIV and HCV infections. Pediatr Dermatol. 2007;24(4):456-457. (Pubitemid 47382854)
21. Hultgren TL, Srinivasan SK, DiMaio DJ. Epidermodysplasia verruciformis occurring in a patient with human immunodeficiency virus: a case report. Cutis. 2007;79(4):307-311.
22. Kroft EB, Melchers WJ, Blokx WA, de Hoop D, Warris A. A generalized skin eruption in a human immunodeficiency virus-infected boy. J Eur Acad Dermatol Venereol. 2008;22(7):896-897. (Pubitemid 351837138)
23. Chen P Jr, Kamino H, Walters RF, Rosenman K, Pomeranz MK, Sanchez M. Epidermodysplasia verruciformis in the setting of HIV infection. Dermatol Online J. 2008;14(10):1.
24. Rallis E, Paparizos V, Kyriakis K, Katsambas A. Treatment of epidermodysplasia verruciformis in human immunodeficiency virus-positive patients. J Eur Acad Dermatol Venereol. 2009;23(2):195-196.
25. Berk DR, Bruckner AL, Lu D. Epidermodysplasia verruciform-like lesions in an HIV patient. Dermatol Online J. 2009;15(1):1.
26. Hohenstein E, Rady PL, Hergersberg M, et al. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A - >T polymorphism in the TMC8/EVER2 gene. Dermatology. 2009;218(2):114-118.
27. Rogers HD, Macgregor JL, Nord KM, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2009;60(2):315-320.
28. Iarikov D, Duke W, Skiest D. Extensive development of flat warts as a cutaneous manifestation of immune reconstitution syndrome. AIDS Read. 2008;18(10):524-527.
29. Kerob D, Dupuy A, Vignon-Pennamen MD, Bournerias I, Dohin E, Lebbe C. A case of efflorescence of cutaneous warts as a manifestation of immune reconstitution inflammatory syndrome in an HIV-infected patient. Clin Infect Dis. 2007;45(3):405-406. (Pubitemid 47101049)
30. Lutzner M, Croissant O, Ducasse MF, Kreis H, Crosnier J, Orth G. A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients. J Invest Dermatol. 1980;75(4):353-356. (Pubitemid 10024621)
31. Rüdlinger R, Smith IW, Bunney MH, Hunter JA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol. 1986;115(6):681-692. (Pubitemid 17181893)
32. Morrison C, Eliezri Y, Magro C, Nuovo GJ. The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients. J Cutan Pathol. 2002;29(8):480-489. (Pubitemid 35034459)
33. Gross G, Ellinger K, Roussaki A, Fuchs PG, Peter HH, Pfister H. Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment. J Invest Dermatol. 1988;91(1):43-48.
34. Kawai K, Egawa N, Kiyono T, Kanekura T. Epidermodysplasia-verruciformis- like eruption associated with gamma-papillomavirus infection in a patient with adult T-cell leukemia. Dermatology. 2009;219(3):274-278.
35. Kunishige JH, Hymes SR, Madkan V, et al. Epidermodysplasia verruciformis in the setting of graft-versus-host disease. J Am Acad Dermatol. 2007;57(5)(suppl): S78-S80. (Pubitemid 47552637)
36. Tanigaki T, Kanda R, Sato K. Epidermodysplasia verruciformis (L-L, 1922) in a patient with systemic lupus erythematosus. Arch Dermatol Res. 1986;278(3):247-248.
37. García-Río I, Garcia-F-Villalta MJ, Daudén E, Fraga J, García-Díez A. Epidermodysplasia verruciformis-like lesions in a patient with systemic lupus erythematosus. Acta Derm Venereol. 2003;83(3):229-230. (Pubitemid 36629834)
38. Tobin E, Rohwedder A, Holland SM, Philips B, Carlson JA. Recurrent 'sterile' verrucous cyst abscesses and epidermodysplasia verruciformis-like eruption associated with idiopathic CD4 lymphopenia. Br J Dermatol. 2003;149(3):627-633. (Pubitemid 37281599)
39. Stetson CL, Rapini RP, Tyring SK, Kimbrough RC. CD4+ T lymphocytopenia with disseminated HPV. J Cutan Pathol. 2002;29(8):502-505. (Pubitemid 35034462)
40. Piketty C, Darragh TM, Heard I, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis. 2004;31(2):96-99. (Pubitemid 38141642)
41. Yutsudo M, Kanda R, Tanigaki T, Kitano Y, Hakura A. Human papillomavirus type 38 isolated from patients with epidermodysplasia verruciformis. Intervirology. 1986;26(1-2):104-108. (Pubitemid 17039215)
42. Bourgault Villada I, Moyal Barracco M, Villada IB, et al. Spontaneous regression of grade 3 vulvar intraepithelial neoplasia associated with human papillomavirus-16- specific CD4(+) and CD8(+) T-cell responses. Cancer Res. 2004;64(23):8761-8766. (Pubitemid 39552094)
43. Coleman N, Birley HD, Renton AM, et al. Immunological events in regressing genital warts. Am J Clin Pathol. 1994;102(6):768-774.
44. Knowles G, O'Neil BW, Campo MS. Phenotypical characterization of lymphocytes infiltrating regressing papillomas. J Virol. 1996;70(12):8451-8458. (Pubitemid 26378422)
45. Bohlius J, Schmidlin K, Costagliola D, et al; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antivir Ther. 2009;14(8):1065-1074.
46. Rodrigues LK, Baker T, Maurer T. Cutaneous warts in HIV-positive patients undergoing highly active antiretroviral therapy. Arch Dermatol. 2001;137(8):1103-1104. (Pubitemid 32756474)
47. van der Burg SH, Palefsky JM. Human Immunodeficiency virus and human papilloma virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med. 2009;7:108.
48. Androphy EJ, Dvoretzky I, Lowy DR. X-linked inheritance of epidermodysplasia verruciformis: genetic and virologic studies of a kindred. Arch Dermatol. 1985;121(7):864-868. (Pubitemid 15070196)
49. Akgül B, Köse O, Safali M, et al. A distinct variant of epidermodysplasia verruciformis in a Turkish family lacking EVER1 and EVER2 mutations. J Dermatol Sci. 2007;46(3):214-216. (Pubitemid 46601835)
50. Zavattaro E, Azzimonti B, Mondini M, et al. Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations. J Invest Dermatol. 2008;128(3):732-735. (Pubitemid 351252678)